Wealth Enhancement Advisory Services LLC Takes $440,000 Position in Tempus AI, Inc. (NASDAQ:TEM)

Wealth Enhancement Advisory Services LLC purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 9,121 shares of the company's stock, valued at approximately $440,000.

Other hedge funds have also made changes to their positions in the company. Operose Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter valued at about $25,000. Farther Finance Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter valued at about $34,000. Prestige Wealth Management Group LLC lifted its stake in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after buying an additional 965 shares during the period. NewEdge Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter valued at about $49,000. Finally, GAMMA Investing LLC bought a new stake in shares of Tempus AI in the first quarter valued at about $105,000. Institutional investors own 24.22% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on TEM. Bank of America raised their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. BTIG Research assumed coverage on shares of Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 price target for the company. Morgan Stanley raised their price target on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Guggenheim raised their price target on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Finally, Piper Sandler raised their price target on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research note on Thursday, May 15th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Tempus AI presently has a consensus rating of "Moderate Buy" and an average price target of $63.67.

Insider Activity at Tempus AI

In related news, EVP Erik Phelps sold 51,317 shares of the company's stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the transaction, the executive vice president owned 97,779 shares in the company, valued at approximately $7,094,844.24. This represents a 34.42% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 20,000 shares of the company's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $52.36, for a total transaction of $1,047,200.00. Following the completion of the transaction, the chief operating officer owned 884,460 shares in the company, valued at approximately $46,310,325.60. This trade represents a 2.21% decrease in their position. The disclosure for this sale can be found here. Insiders sold 607,522 shares of company stock worth $41,300,238 over the last ninety days. Company insiders own 27.60% of the company's stock.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $60.65 on Monday. The firm has a 50 day simple moving average of $62.53 and a 200 day simple moving average of $54.27. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56. Tempus AI, Inc. has a fifty-two week low of $30.81 and a fifty-two week high of $91.45. The firm has a market cap of $10.50 billion and a P/E ratio of -7.78.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The business had revenue of $255.74 million for the quarter, compared to analysts' expectations of $248.13 million. The firm's quarterly revenue was up 75.4% compared to the same quarter last year. Sell-side analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.